FORVEL

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, Lithuania, Malta, Romania.

Active ingredients

The drug FORVEL contains one active pharmaceutical ingredient (API):

1
UNII 5Q187997EE - NALOXONE HYDROCHLORIDE DIHYDRATE
 

Naloxone hydrochloride, a semisynthetic morphine derivative (N-allyl-nor-oxymorphone), is a specific opioid antagonist that acts competitively at opioid receptors. It reveals very high affinity for the opioid receptor sites and therefore displaces both opioid agonists and partial antagonists, such as pentazocine, for example, but also nalorphine.
 
Read more about Naloxone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
V03AB15 Naloxone V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AB Antidotes
Discover more medicines within V03AB15

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1712898, 1712900
HR Agencija za lijekove i medicinske proizvode HR-H-408963010
LT Valstybinė vaistų kontrolės tarnyba 1083769, 1083770
MT Medicines Authority MA032/10601
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W64182001, W64182002

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈